Proteomics

Dataset Information

0

Mitoxantrone impacts on proteoform abundance in HR proficient and deficient ovarian cancer cells


ABSTRACT: Mitoxantrone (MX) is regularly used to treat several cancers, yet despite its long history in the clinic, recent studies continue to unveil novel protein targets that may contribute to the cytotoxic effects of the drug, as well as potential non-canonical antitumor activity. A better understanding of MX’s cellular targets is required to fully comprehend the molecular consequences of treatment and to interpret MX-sensitivity in homologous recombination (HR)-deficient cancer. The mass spectrometry samples reported here represent the analysis of MX impacts on proteoform abundance in HR-deficient or proficient UWB1.289 ovarian cancer cells using TMT-labeled quantitative proteomics.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

DISEASE(S): Malignant Neoplasm Of Ovary

SUBMITTER: Nicholas Woods  

LAB HEAD: Nicholas Woods

PROVIDER: PXD069401 | Pride | 2025-12-01

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20250214_SW_F.msf Msf
20250214_SW_F1.raw Raw
20250214_SW_F10.raw Raw
20250214_SW_F11.raw Raw
20250214_SW_F12.raw Raw
Items per page:
1 - 5 of 14
altmetric image

Publications

Surveying the Proteome-Wide Landscape of Mitoxantrone and Examining Drug Sensitivity in BRCA1-Deficient Ovarian Cancer Using Quantitative Proteomics.

Wallin Savanna S   Pandithar Sneha S   Singh Sarbjit S   Kumar Siddhartha S   Natarajan Amarnath A   Borgstahl Gloria E O GEO   Woods Nicholas N  

Proteomes 20251114 4


<b>Background</b>: Mitoxantrone (MX) is regularly used to treat several cancers. Despite its long history in the clinic, recent studies continue to unveil novel protein targets. These targets may contribute to the cytotoxic effects of the drug, as well as potential non-canonical antitumor activity. A better understanding of MX's cellular targets is required to fully comprehend the molecular consequences of treatment and to interpret MX sensitivity in homologous recombination (HR)-deficient cance  ...[more]

Similar Datasets

2025-12-01 | PXD069034 | Pride
2020-04-23 | PXD010425 | Pride
2012-10-03 | E-GEOD-36876 | biostudies-arrayexpress
2013-07-01 | E-GEOD-43528 | biostudies-arrayexpress
2023-04-27 | PXD034050 | Pride
2023-04-27 | PXD036110 | Pride
2009-03-31 | E-MEXP-1867 | biostudies-arrayexpress
2017-02-14 | E-MTAB-5465 | biostudies-arrayexpress
2010-07-05 | E-GEOD-22481 | biostudies-arrayexpress
2012-10-03 | E-GEOD-39110 | biostudies-arrayexpress